---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-024626"
form_type: "8-K"
ticker: "IMMX"
cik: "0001873835"
company_name: "Immix Biopharma, Inc."
filed_at: "2023-07-14T23:59:59+00:00"
generated_at: "2026-06-13T08:26:50.902840+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Immix Biopharma enters ATM equity offering agreement with ThinkEquity LLC

## Summary
- ATM Sales Agreement with ThinkEquity LLC allows at-the-market sales of common stock, subject to $75M public float limitation.
- Commission rate of 3.75% of gross proceeds; company also reimburses legal fees up to $50,000 and quarterly fees.
- Sales may occur on Nasdaq Capital Market or other trading markets at prevailing prices; agreement terminable on 10 days' notice.
- Prospectus supplement filed July 14, 2023 under effective shelf registration statement (333-269100).

## SEC filing metadata
- accession: 0001493152-23-024626
- form_type: 8-K
- ticker: IMMX
- cik: 0001873835
- company_name: Immix Biopharma, Inc.
- filed_at: 2023-07-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1873835/000149315223024626/0001493152-23-024626-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1873835/000149315223024626/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-024626
- JSON: https://secwatch.observer/filing/0001493152-23-024626.json
- Plain text: https://secwatch.observer/filing/0001493152-23-024626.txt

## Key facts
- Material Agreements
  Immix Biopharma, Inc. entered into ATM Sales Agreement with ThinkEquity LLC (effective 2023-07-14).
  - Action: entry
  - Agreement: atm program
  - Counterparty: ThinkEquity LLC
  - Effective: 2023-07-14
  source text: On July 14, 2023, Immix Biopharma, Inc. (the “Company”) entered into an ATM Sales Agreement (the “Sales Agreement”) with ThinkEquity LLC (the “Sales Agent”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1873835/000149315223024626/0001493152-23-024626-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.